Forty Seven Inc. Expands Collaboration with Genentech to Include Third Clinical Trial in Non-Hodgkin’s Lymphoma

    NEXT STORY
    Oncology Venture Investor Events in Q2 2019
    PREV STORY
    Editorial in Pharmagenomics explains how DRP® can guide the treatment for breast cancer
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Kleo Pharmaceuticals Presents Preclinical Data on KPMW135, a Novel CD3 x CD20 Bispecific Version of Rituximab, Showing Increased Anti-Tumor Activity Compared to Rituximab, at The 62nd Annual American Society of Hematology (ASH) Meeting

    author_avatar
    NASDAQ Market News

    Real-world Evidence (RWE) Solutions Market to Reach $3.13 Billion by 2027, Growing at a CAGR of 16.5%, Says Meticulous Research®

    author_avatar
    NASDAQ Market News

    Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared

    author_avatar
    NASDAQ Market News